NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) —<\/p>\n
WHY:\u00a0<\/strong>Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0October 28, 2024 lead plaintiff deadline.<\/strong><\/p>\n SO WHAT:<\/strong>\u00a0If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.<\/p>\n WHAT TO DO NEXT:\u00a0<\/strong>To join the Outset Medical class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=17760<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0case@rosenlegal.com<\/a>\u00a0for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court\u00a0no later than October 28, 2024.\u00a0<\/strong>A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n WHY ROSEN LAW:\u00a0<\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition.\u00a0Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases.\u00a0<\/strong>Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n DETAILS OF THE CASE:\u00a0<\/strong>According to the lawsuit, during the Class Period, defendants made false and\/or misleading statements and\/or failed to disclose that: (1) the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the United States Food and Drug Administration (\u201cFDA\u201d); (2) as a result, Outset Medical was reasonably likely to submit an additional 510(k) application for the Tablo products; (3) there was a substantial risk that Outset Medical would cease sales of the Tablo products pending FDA approval of additional indications; (4) Outset Medical lacked the sales team and process to execute on the ramp of Tablo sales; (5) as a result of the foregoing, Outset Medical\u2019s revenue growth would be adversely impacted; and (6) as a result of the foregoing, defendants\u2019 positive statements about Outset Medical\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n To join the Outset class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=17760<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0case@rosenlegal.com<\/a>\u00a0for information on the class action.<\/p>\n No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n Follow us for updates on LinkedIn:\u00a0https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter:\u00a0https:\/\/twitter.com\/rosen_firm<\/a>\u00a0or on Facebook:\u00a0https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n ——————————-<\/p>\n Contact Information:<\/p>\n Laurence Rosen, Esq. GlobeNewswire Distribution ID 9234230<\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) \u2014 WHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0October 28, 2024 lead plaintiff deadline. SO WHAT:\u00a0If you purchased Outset Medical [\u2026]<\/p>\n<\/div>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2371],"tags":[229,230],"class_list":["post-275463","post","type-post","status-publish","format-standard","hentry","category-press-releases","tag-mena","tag-pakistan"],"yoast_head":"\n
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\ncase@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a><\/p>\n